A <i>POLR1D</i> -regulating single-nucleotide polymorphism as a predictive marker candidate for platinum-based chemotherapy in gastrointestinal cancers
Given the centrality of platinum-based drugs in cancer therapy, our findings align with biochemical evidence and prior literature, highlighting rs12876842 as a promising prognostic biomarker.
Authors
- Masao Nagasaki
- Takahiro Mori (ORCID: https://orcid.org/0000-0001-7324-8574)
- Kazuko Ueno (ORCID: https://orcid.org/0000-0003-3194-0735)
- Koichi Matsuda (ORCID: https://orcid.org/0000-0001-7292-2686)
Institutions
- Kyushu University (JP)
- Kyoto University (JP)
- National Center for Global Health and Medicine (JP)
- Kyushu University Hospital (JP)
- Okinawa Prefectural Chubu Hospital (JP)
- The University of Tokyo (JP)
Publication Details
- Journal
- Therapeutic Advances in Medical Oncology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1177/17588359251355079
- Primary Topic
- Kruppel-like factors research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Agency for Medical Research and Development